Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

23andMe's big push into drug development, announced with great fanfare ... The restructuring comes after a turbulent period at 23andMe, with a steep decline in its share price – down more ...

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Total revenue in the first quarter was $1 ...

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

Rising drug costs are shaking the foundation of Michigan’s health care industry, with the potential to push the market to ...